Home › Funds › VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. › GILD

VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. position in GILD

GILEAD SCIENCES INC · Health Care

VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. reported holding 472,181 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$70.4M, representing 0.53% of its reported portfolio and ranking #31 among its reported holdings. VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)472.18K sh
Reported value held$70.38M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.'s GILD position evolved

VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. first disclosed a stake in GILD in Q3 2023 at 478,625 shares (US$35.9M). The position peaked in Q3 2026 at 472,181 shares, worth US$70.4M. Across 13 filings, VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 472,181 shares valued at US$70.4M — a reduction of -17,679 shares quarter over quarter.. Notable position changes include a 35% trim in Q4 2024 (shares rose 21% over the following quarter), a 83% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 478.62K $35.87M New
Q4 2023 495.13K $40.11M Add
Q1 2024 517.66K $37.92M Add
Q2 2024 548.99K $37.67M Add
Q3 2024 502.81K $42.16M Reduce
Q4 2024 328.64K $30.36M Reduce
Q1 2025 327.29K $36.67M Hold
Q2 2025 269.60K $29.89M Reduce
Q3 2025 264.50K $29.36M Reduce
Q4 2025 267.70K $32.86M Add
Q1 2026 267.25K $37.25M Hold
Q2 2026 489.86K $61.89M Add
Q3 2026 472.18K $70.38M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. held GILD?

VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.'s current position in GILD?

As of Q3 2026, VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. holds 472.18K shares of GILD (GILEAD SCIENCES INC), valued at $70.38M, representing 0.53% of its reported portfolio and ranking #31.

Has VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. been buying or selling GILD?

In the latest 13F filing (Q3 2026), VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. reduced its position in GILD. The position peaked in Q3 2026 at 472.18K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.